Inhibitors of HCV NS5B polymerase
US7026339B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Inventors
Key dates
| Filing date | Nov 3, 2004 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Jan 15, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds, process for their synthesis, compositions and methods for the treatment and prevention of hepatitis C virus (HCV) infection. In particular, the present invention provides novel compounds, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment or prevention of HCV infection. The present invention also provides processes and intermediates for the synthesis of these compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.